rethinkPeptides Search
Menu
RethinkPeptides

Selank research

Explore studies of selank.

Filter by topic, method, and evidence

You can select more than one topic or evidence level.

Clear filters

RPEP-00708 · 2001

Selank Treats Anxiety by Protecting the Body's Natural Anxiety-Relieving Enkephalins

Anxiety patients showed accelerated enkephalin degradation, and Selank's anxiolytic effect correlated with inhibition of enkephalin-degrading enzymes, preserving endogenous opioid-mediated anxiety relief.

Zozulya, A A; Kost, N V; Yu Sokolov, O; Gabaeva, M V; Grivennikov, I A; Andreeva, L N; Zolotarev, Y A; Ivanov, S V; Andryushchenko, A V; Myasoedov, N F; Smulevich, A B · Clinical Trial

RPEP-00838 · 2003

Selank Improves Learning and Memory Specifically in Low-Performing Rats

Selank selectively enhanced conditioned avoidance learning and memory in rats with initially low learning ability while minimally affecting normal learners, demonstrating deficit-correcting rather than general cognitive enhancement.

Kozlovskii, I I; Danchev, N D · Animal Study

RPEP-01163 · 2006

Selank's Anti-Anxiety Effect Involves the Opioid System: Naloxone Blocks Its Action

Naloxone blocked Selank's depriming effect on apomorphine-induced dopaminergic behavioral manifestations, directly confirming opioid system involvement in Selank's anxiolytic mechanism — linking its anti-anxiety action to enkephalin protection.

Meshavkin, V K; Kost, N V; Sokolov, O Yu; Zolotarev, Yu A; Myasoedov, N F; Zozulya, A A · Animal Study

RPEP-05052 · 2020

Selank and Semax Alter Brain Connectivity Between Amygdala and Temporal Cortex in Humans

Both Selank and Semax modulated functional connectivity between right amygdala and right temporal cortex regions (fusiform, inferior/middle temporal, parahippocampal gyri) with both shared and peptide-specific effects.

Panikratova, Ya R; Lebedeva, I S; Sokolov, O Yu; Rumshiskaya, A D; Kupriyanov, D A; Kost, N V; Myasoedov, N F · Rct